In-Vitro Bioequivalence of Amoxicillin and Clavulanic acid products available in Syrian market using Derivative Spectrophotometry
Abstract
Bioequivalence (BE) is an essential requirement for interchanging brand and generic drugs. It could be evaluated In Vivo or In Vitro, and should be carried out for all pharmaceutical products “single drug or combinated drugs”. For the latter, BE studies are often carried out by means of chromatographic methods (HPLC), where it is not possible to use spectrophotometry because of drugs that absorb at the same spectral region such as the binary mixture of amoxicillin and clavulanic acid. This study aimed to carry out BE test of Augmentin (Amoxicillin and Clavulanic acid) products manufactured and available in Syrian market by using Derivative spectrophotometry. First order and Zero-Crossing technique were used for simultaneous determination of these drugs. Three local companies A, B and C were tested and compared with the brand using dissolution test and calculating fit factors (dissimilarity factor ????1 and similarity factor ????2). Other quality control tests were carried out. All tablets achieved weight uniformity and had good hardness with a disintegration time of less than 30 minutes. Weight variation test (content of amoxicillin) was achieved for all samples, while content uniformity of clavulanic acid was not achieved. For dissolution test, only one sample was bioequivalent with brand (for amoxicillin), however no sample was bioequivalent (for clavulanic acid).
Downloads
Published
How to Cite
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.